94
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Advanced Hepatocellular Carcinoma in Adults Without Cirrhosis: A Single-Institution Retrospective Review

ORCID Icon, , , , , , , , ORCID Icon, , , & show all
Pages 1299-1307 | Received 19 Aug 2022, Accepted 22 Oct 2022, Published online: 19 Dec 2022

References

  • Zhuo Y, Chen Q, Chhatwal J. Hepatocellular carcinoma, translational precision medicine approaches. Mol Transl Med. 2019;5:53–67.
  • Llovet JM, Kelley RK, Villanueva A, et al. Hepatocellular carcinoma. Nat Rev Dis Primers. 2021;7(1):6. doi:10.1038/s41572-020-00240-3
  • Desai A, Sandhu S, Lai JP, Sandhu DS. Hepatocellular carcinoma in non-cirrhotic liver: a comprehensive review. World J Hepatol. 2019;11(1):1–18. doi:10.4254/wjh.v11.i1.1
  • Lee DH, Lee JM. Primary malignant tumours in the non-cirrhotic liver. Eur J Radiol. 2017;95:349–361. doi:10.1016/j.ejrad.2017.08.030
  • Schütte K, Schulz C, Poranzke J, et al. Characterization and prognosis of patients with hepatocellular carcinoma (HCC) in the non-cirrhotic liver. BMC Gastroenterol. 2014;14(1):117. doi:10.1186/1471-230X-14-117
  • Giannini EG, Marenco S, Bruzzone L, et al. Hepatocellular carcinoma in patients without cirrhosis in Italy. Digest Liver Dis. 2013;45(2):164–169. doi:10.1016/j.dld.2012.08.018
  • Mergental H, Adam R, Ericzon BG, et al. Liver transplantation for unresectable hepatocellular carcinoma in normal livers. J Hepatol. 2012;57(2):297–305. doi:10.1016/j.jhep.2012.03.022
  • Weinmann A, Koch S, Niederle IM, et al. Trends in epidemiology, treatment, and survival of hepatocellular carcinoma patients between 1998 and 2009. J Clin Gastroenterol. 2014;48(3):279–289. doi:10.1097/MCG.0b013e3182a8a793
  • Nzeako UC, Goodman ZD, Ishak KG. Hepatocellular carcinoma in cirrhotic and noncirrhotic livers: a clinico-histopathologic study of 804 North American Patients. Am J Clin Pathol. 1996;105(1):65–75. doi:10.1093/ajcp/105.1.65
  • Smalley SR, Moertel CG, Hilton JF, et al. Hepatoma in the noncirrhotic liver. Cancer. 1988;62(7):1414–1424. doi:10.1002/1097-0142(19881001)62:7<1414::AID-CNCR2820620729>3.0.CO;2-7
  • Meer S, Erpecum KJ, Sprengers D, et al. Hepatocellular carcinoma in cirrhotic versus noncirrhotic livers. Eur J Gastroen Hepat. 2016;28(3):352–359. doi:10.1097/MEG.0000000000000527
  • Desai A, Sandhu S, Lai JP, Sandhu DS. Hepatocellular carcinoma in non-cirrhotic liver: a comprehensive review. World J Hepatol. 2019;11(1):1–18.
  • Borie F, Bouvier A, Herrero A, et al. Treatment and prognosis of hepatocellular carcinoma: a population based study in France. J Surg Oncol. 2008;98(7):505–509. doi:10.1002/jso.21159
  • El-Serag HB. Hepatocellular Carcinoma. New Engl J Medicine. 2011;365(12):1118–1127. doi:10.1056/NEJMra1001683
  • Wörns MA, Bosslet T, Victor A, et al. Prognostic factors and outcomes of patients with hepatocellular carcinoma in non-cirrhotic liver. Scand J Gastroentero. 2012;47(6):718–728. doi:10.3109/00365521.2012.677952
  • Grazi GL, Cescon M, Ravaioli M, et al. Liver resection for hepatocellular carcinoma in cirrhotics and noncirrhotics. Evaluation of clinicopathologic features and comparison of risk factors for long‐term survival and tumour recurrence in a single centre. Aliment Pharm Therap. 2003;17(s2):119–129. doi:10.1046/j.1365-2036.17.s2.9.x
  • Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–86. doi:10.1002/ijc.29210
  • Boudjema K, Compagnon P, DuPont-Bierre E, et al. Transplantation hépatique pour carcinome hépatocellulaire. Cancer Radiothérapie. 2005;9(6–7):458–463. doi:10.1016/j.canrad.2005.09.009
  • Perisetti A, Goyal H, Yendala R, Thandassery RB, Giorgakis E. Non-cirrhotic hepatocellular carcinoma in chronic viral hepatitis: current insights and advancements. World J Gastroentero. 2021;27(24):3466–3482. doi:10.3748/wjg.v27.i24.3466
  • Mazzotta AD, Pascale A, Cano L, et al. Number of hepatocellular carcinoma nodules in patients listed for liver transplantation within alpha‐fetoprotein score: a new prognostic risk factor. Transplant Int. 2021;34(5):954–963. doi:10.1111/tri.13858
  • Wang K, Qiu X, Zhao Y, Wang H, Chen L. The Wnt/β-catenin signaling pathway in the tumor microenvironment of hepatocellular carcinoma. Cancer Biol Med. 2022;19(3):305–318.
  • Gaddikeri S, McNeeley MF, Wang CL, et al. Hepatocellular carcinoma in the noncirrhotic liver. Am J Roentgenol. 2014;203(1):W34–47. doi:10.2214/AJR.13.11511